Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Rectal Diseases 1Neoplasms by Site 1Neoplasms 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Digestive System Neoplasms 1Digestive System Diseases 1Colonic Diseases 1

Interventions

alvimopan 5Irinotecan 4Oxaliplatin 3Capecitabine 3Bevacizumab 3Leucovorin 2Fluorouracil 2Cyclophosphamide 2Cetuximab 2Aspirin 2repotrectinib 1pralsetinib 1pembrolizumab 1napabucasin 1guadecitabine 1encorafenib 1alectinib 1Ursodeoxycholic Acid 1Surveys and Questionnaires 1Pemetrexed 1Oviposition 1Ocoxin 1Levoleucovorin 1KRN-330 1Folfox protocol 1Exercise 1Drug Therapy 1Drainage 1Chemoradiotherapy 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Intestinal Diseases × KRN-330 × Clear all
NCT00838578 2024-04-26

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

Kyowa Kirin Co., Ltd.

Phase 1/2 Terminated
65 enrolled 7 charts
Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡